Mice are excellent experimental models for genetic research and are being used to investigate the genetic component of organismal aging. Several mutant mice are known to possess defects in the growth hormone/insulin-like growth factor 1 (GH/IGF-1) neurohormonal pathway and exhibit dwarfism together with extended life span. Their phenotypes resemble those of mice subjected to caloric restriction. Targeted mutations that affect components of this pathway, including the GH receptor, p66Shc, and the IGF-1 receptor (IGF-1R), also extend life span; mutations that affect IGF-1R or downstream components of the pathway decouple longevity effects from dwarfism. These effects on life span may result from an increased capacity to resist oxidative damage.
been found that rats (http://sageke.sciencemag.org/cgi/genedata/ sagekeGdbIntrvn;11) undergoing CR display a higher per-unit lean body mass metabolism than do rats fed ad libitum (AL), despite a lowered caloric intake (30) . CR-induced life span extension does not, therefore, appear to result from a reduced metabolic rate.
CR initiated in mice in young adulthood results in (i) lower plasma glucose and IGF-1 concentrations; (ii) protection against autoimmune disorders; (iii) elevated levels of apoptosis in tumors; (iv) reduced angiogenesis; (v) postponed or attenuated onset of cancer, immunosenescence, and inflammation; and (vi) delayed onset of other age-related diseases, all without irreversible side effects (31) (32) (33) (34) (35) (36) (37) . A recent large-scale investigation of CR effects also revealed inhibition of cardiac, renal, and central nervous system pathologies, as well as decreased bone degeneration, atrophy of secretory organs, amyloid induction, and hyperplasia (38) . In general, mice undergoing CR maintain robust physiological and immunological responses longer into life than do their AL-fed counterparts (39, 40) .
Reduced oxidative damage is one popular explanation for the effects of CR; however, because this effect does not result from CR-related changes in metabolic activity, other factors may cooperate with alterations in resistance to damaging reactive oxygen species (ROS) to extend life span (41) (42) (43) . Reduced insulin levels lead to reduced glycemia-related glycation of proteins and nucleic acids; lowering insulin levels in C. elegans nervous tissue leads to an increase in life span (11, 44, 45) . Mammals also exhibit a down-regulation of the GH/IGF-1 axis after CR, which might be related to the extended life span phenotype (46) (47) (48) .
Another idea is that CR works by triggering an innate beneficial response to low-level stressors. This effect, in which a low caloric intake engenders a state of preparedness for other stresses, is known as hormesis. CR does enhance the induction of stress proteins in response to cellular damage (including ROS-induced damage). Furthermore, mice undergoing CR respond better to surgery and toxic chemical challenges than do AL-fed mice (49) .
The effects of CR on human life span are still not known definitively, although long-term studies are in progress. There is evidence that humans with lower than normal body temperatures and reduced insulin levels might live longer than average (50) . Researchers are also working on understanding the effects of CR in primates (51) (see also "Monkey in the Middle" at http://sageke.sciencemag.org/cgi/content/abstract/sageke;2002/ 31/nw108).
Mutant Mice That Live Longer Than the Wild Type
Researchers interested in aging have carried out a considerable amount of work using mice with the aim of understanding the genetic basis of life span determination and, in particular, of identifying alleles of specific genes that allow for long life span. Several long-lived mutants have been identified and characterized, including the Ames, Snell, Little, and Laron mice (see Bartke Viewpoint at http://sageke.sciencemag.org/cgi/ content/full/sageke;2002/16/vp4).
Ames and Snell mice are long-lived dwarfs, exhibiting a phenotype similar to that seen in mice that undergo CR throughout their life spans. These mice lack GH-producing cells in the pituitary gland; in Ames mice because of a recessive point mutation in the Prop1 (http://sageke.sciencemag.org/cgi/ genedata/sagekeGdbGene;116) gene (which encodes a transcription factor involved in embryonic development of the anterior pituitary gland), and in Snell mice because of a mutation in the Pit1 (http://sageke.sciencemag.org/cgi/genedata/sagekeGdbGene;113) gene, which also results in altered anterior pituitary development (52) (53) (54) .
Ames mice
The first mammalian mutant found to have an increased average and maximal life span was the Ames mouse (http://sageke. sciencemag.org/cgi/content/full/sageke;2001/1/tg11). Depending on gender and genetic background, extensions of about 50% in average life span and 40% in maximal life span are observed. The Ames mouse is of considerable significance: Preliminary evidence suggests that humans with mutated Prop1 may show increased longevity (54) (and see "Power to the People" at http://sageke.sciencemag.org/cgi/content/full/2003/50/ns8).
Ames mice display phenotypes of dwarfism (they are about one-third normal size), reduced growth rate, and deficiencies in GH, prolactin, thyroid-stimulating hormone (TSH), and IGF-1. Males exhibit variable fertility, but females are infertile as a result of a lack of prolactin (treatment with prolactin restores fertility). Both genders display delayed reproductive maturity. A number of aging-related phenotypes are also seen: renal pathology; changes in collagen; and declines in immune function, locomotor activity, learning, and memory. Reduced or delayed tumor development is also observed (55) (56) (57) .
CR treatment of Ames mice results in a further life span extension, indicating separate (though probably not fully independent) underlying mechanisms. A mechanistic difference is also possible because CR decelerates aging (the slope of the mortality curve decreases), whereas the mutation in Prop1 delays it [the mortality curve shifts to the right but maintains its shape (43) ]. The general effect of CR on murine life span may therefore not be entirely a result of altered pituitary function, although this idea has been contested (58) . The life span extension in Ames mice might also be caused by their lowered core body temperature (a reduction of 1.5°C as compared to the wild type) or increased expression of antioxidants [modest increases in the abundance of SOD1 and catalase are seen (43, 56, 57) ].
Reduced prolactin abundance might also contribute to life span extension in these mice, because impaired bone mineralization and fat deposition are observed. These changes are consistent with the phenotype of the prolactin receptor knockout mouse (59) . The sensitive glucose response of the Ames mouse might also be related to effects of reduced prolactin concentration on body fat (59) . With respect to reduced TSH levels, artificially induced hypothyroidism in rats does extend life span. Longevity studies will need to be performed on genetically altered mice with specific defects in prolactin or TSH signaling in order to determine whether the altered prolactin and TSH phenotypes of the Ames dwarf influence life span.
Snell mice
Most of the phenotypes exhibited by Ames mice are shared by Snell dwarfs (http://sageke.sciencemag.org/cgi/content/ full/sageke;2001/3/tg13). Snell mice have a mutation in the Pit1 gene, which also results in deficient GH, prolactin, and TSH production. Their life spans are similarly extended (53) . Other signs of slowed aging are also observed, including slower immune, joint, and connective tissue senescence (52) . Skin-derived fibroblast cell cultures from Snell mice show increased re-sistance to many forms of stress, including ultraviolet (UV) light, heat, paraquat (an ROS-producing herbicide), H 2 O 2 , and the toxic metal cadmium. This result supports the notion of a link between greater resistance to cellular stress and slowed aging, and also suggests that the altered hormonal profiles in dwarf mice cause long-lasting physiological changes that promote longevity in various cell types (60) .
Lowered GH concentrations might be a major cause of the increased longevity observed in both Ames and Snell mice. GH overexpression shortens life span and is accompanied by symptoms of early aging, including shortened reproductive life span, increased astrogliosis and plasma corticosterone concentrations, and early-onset agingrelated effects on cognitive function (61) . Circulating insulin concentrations also decrease in Snell mice, resulting in reduced insulin/IGF-1 signaling. These signals are normally transmitted through phosphoinositide 3-kinase (PI3K) and Grb2 via insulin receptor substrate 2 (IRS-2), a tyrosine-phosphorylated protein functionally similar to but slightly larger than and immunologically distinct from IRS-1 (the primary mediator of insulin signaling). Consequences of reduced signaling include a smaller pool of IRS-2 and therefore less IRS-2-associated PI3K activity. The insulin receptor β-IRS-1-PI3K signaling pathway in Snell mouse livers is also attenuated. Interestingly, aged Snell mouse livers preferentially form PI3K complexes that have a p85α-p110α composition rather than a p85α-p110β composition; the preference for p110α complexes of PI3K has been proposed to be a potentially important characteristic of the longevity-signaling cascade (62, 63) .
Little mice
The aptly named "Little" mice (http://sageke. sciencemag.org/cgi/content/full/sageke; 2001/4/tg14) have a recessive mutation in ghrhr (http://sageke.sciencemag.org/cgi/ genedata/sagekeGdbGene;61), the gene encoding the GH-releasing hormone receptor. This mutation results in a profound but incomplete GH deficiency, making the observed phenotypes distinct from those resulting from the combined effects on prolactin and TSH concentrations in the Ames and Snell mice. Little mice also experience stunted growth, but grow to about one-half normal size rather than one-third, as seen in the Ames and Snell mice. Little mice also display a more modest 23 to 25% extension of life span, and only when maintained on a low-fat diet (52) . The GH insufficiency causes lowered plasma IGF-1 concentrations (as in the Ames and Snell dwarfs), although this reduction is more predominant in the peripheral circulation than in many organs (64, 65) .
Laron mice
Whereas the mutant mice described above are GH-deficient, Laron mice (http://sageke.sciencemag.org/cgi/content/ full/sageke;2002/8/tg1) lack a growth hormone receptor [GHR (http://sageke.sciencemag.org/cgi/genedata/sagekeGdbGene;246)] because of a targeted knockout of the gene (GHR -/-) and are thus GH-resistant. An important caveat to any observed phenotypes in these mice is that the gene targeted in Laron mice also encodes the GH binding protein (a product resulting from cleavage of the extracellular domain of GHR). These mice were developed to model the complete GH deficiency seen in human Laron dwarfism syndrome (http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=262500). Growth is stunted in Laron mice (adults are half the size of wild-type adults), and concentrations of circulating IGF-1 are very low to undetectable. The lack of negative feedback of IGF-1 on GH secretion results in higher concentrations of circulating GH and elevated prolactin production. Plasma insulin and glucose concentrations are lower than usual in the Laron mouse, but insulin responsiveness is augmented, and reduced insulin release causes lowered glucose tolerance. Because of a lack of IGF-1 action, thyroid hormone levels are low and a lower core body temperature results (64, 66) .
Despite delayed reproductive maturity, Laron mice are generally fertile, albeit at reduced levels, and are deficient in endocrine control of the gonads (64, 66) . They demonstrate delayed age-related cognitive decline, and a 37 to 55% increase in both average and maximal life spans (56, 64, 67, 68) . Human sufferers of Laron syndrome are slightly immunodeficient; however, their growth is stunted, and preliminary evidence indicates increased life span in some patients (54, 69) . The similar phenotypes of the Ames, Snell, Little, and Laron mice indicate that the GH/IGF-1 axis is a major contributor to longevity effects. But what occurs downstream of these signaling pathways to bring about the observed phenotypes? In invertebrates, DAF-2 is the primary effector molecule of the insulinlike signaling pathway, and because of its prior link to life span determination, many genes and gene products known to be affected by DAF-2 activity can serve as clues to mechanisms that might be operating in long-lived mice.
p66shc mutant mice
In 1999, the p66Shc protein (http://sageke.sciencemag.org /cgi/genedata/sagekeGdbGene;105) became the first downstream effector of the GH/IGF-1 pathway to be linked to life span extension in mice. p66Shc is derived from one of three alternate transcripts of the shc gene, and all the encoded proteins bind SOS (a guanine nucleotide exchange factor) upon tyrosine phosphorylation as part of a signaling pathway triggered by activated Ras (http://sageke.sciencemag.org/cgi/content/ abstract/2002/32/nw114) (70) . It is, therefore, a component of a central biochemical pathway linking cell surface receptors to alterations in gene expression. p46Shc and p52Shc, the proteins derived from the other two alternate shc transcripts, have been implicated in cytoplasmic propagation of growth, whereas p66Shc appears to be involved in apoptogenic signaling, which might indicate a basis for a distinction between the growth and life span extension phenotypes seen in the above mutants (71) .
p66Shc is serine-phosphorylated upon binding SOS or upon induction by oxidative stress, in association with or independent of tyrosine phosphorylation, and this mechanism is lost in the p66shc -/-mouse (http://sageke.sciencemag.org/cgi/content/ full/sageke;2003/8/tg4). Furthermore, the p66shc promoter is differentially histone-deacetylated and methylated as compared to the other shc splicing products, which specifically alters transcription of the p66shc alternate transcript (71) (72) (73) .
The p66shc -/-mouse has a 30% longer life span than control mice, a very significant increase in life span in the complex and highly redundant mammalian system. This is equivalent to the life span extension observed in mice being treated with a 40% reduction in caloric intake. Cells from p66shc -/-mice were found to be resistant to UV-and H 2 O 2 -induced (via paraquat treatment) cell death but not resistant to gamma irradiation, indicating that an improved stress response results but is likely limited to oxidative damage (13, 73) .
The actual molecular cascade leading to oxidative stress resistance in cell cultures from p66shc -/-mice is unclear. Although expression of the cell-cycle inhibitor p21 (waf/cip-1) is down-regulated in these mice (p21 is involved in cellular stress response via upregulation by p53), cells derived from p21 -/-mice are known to have a normal oxidative stress response. However, p66shc -/-mice overexpress catalase, and derived cell cultures display reduced apoptosis in response to oxidative stress. The increase in longevity observed in the p66shc -/-mice could therefore be caused by an elevated damage response and/or reduced damage-induced apoptosis (70, 73) (and see "One for All" at http://sageke.sciencemag.org/cgi/content/ full/2002/49/nf15).
Perhaps the most important aspect of the p66shc -/-mouse is that it displays normal size, development, and fertility, in contrast with the negative physiological characteristics seen in the GH-deficient dwarf mice. This mouse therefore provides a model of life span extension and oxidative stress response without complicating physiological phenotypes. It indicates that oxidative damage resistance likely has a direct and separable influence on longevity and that other phenotypes observed in the dwarf mice result from distinct pathways. Negative side effects might still exist in p66shc -/-mice, but different conditions from those already examined would be required to evoke them (70) .
Provision of a high-fat diet had practically no effect on p66shc -/-mutant mice, whereas this diet resulted in an increased aortic cumulative early lesion area, apoptotic vascular cells, systemic and tissue oxidative stress, and other signs of early atherogenesis in wild-type mice. The p66shc -/-mouse might therefore be an excellent model for vascular disease therapy as well as longevity (70, 73, 74) . Crossing of p66shc -/-mutants with more robust outbred mice would determine whether the life span extension phenotype occurs in other, more natural genetic backgrounds.
IGF-1R knockout mice
The second genetically altered mouse to be produced in order to explore the significance of the GH/IGF-1 signaling pathway was the IGF-1R knockout (http://sageke.sciencemag.org/cgi/ content/full/sageke;2003/8/tg1). This strain was created via a CreloxP system, which can be used to inactivate specific mouse genes in a tissue-or time-specific fashion. IGF-1R (http://sageke. sciencemag.org/cgi/genedata/sagekeGdbGene;287) is the mammalian equivalent of DAF-2. In higher organisms, the insulin and IGF-1 pathways are separate; the insulin receptor regulates energy metabolism (75), whereas IGF-1R mediates growth (65) .
Mice that are homozygous for a knockout of the gene encoding IGF-1R are inviable, but female heterozygotes exhibit a phenotype of 30% life span extension. This effect is highly influenced by gender: Male life span extension is observed (16%) but is not statistically significant (76) . As with other mutations that interfere with functions of the GH/IGF-1 axis, life span extension is associated with greater resistance to oxidative stress in derived cell cultures and occurs to a similar extent. Females display greater resistance to paraquat than males, and both genders are more resistant than wild-type controls (76) .
Cultured IGF-1R +/-embryonic fibroblasts display a decrease in the phosphorylation of IGF-1R substrates such as IRS-1, p66Shc, and p52Shc. Furthermore, binding of major downstream targets of p66Shc-Grb2, ERK1/2 (http://sageke. sciencemag.org/cgi/content/abstract/2002/1/nw5), and Akt (http://sageke.sciencemag.org/cgi/content/full/2004/8/pe8)-to p66Shc is reduced by 50% in these cells. Any of these changes might contribute to the observed enhancement in oxidative stress response (76) .
As with p66shc -/-mice, life span extension in IGF-1R +/-animals is uncoupled from growth reduction (the size and weight of both genders are decreased by only 6 to 8%). This uncoupling therefore occurs at the level of IGF-1R. Also, as seen in the p66shc -/-mice, there are no effects on metabolism, fertility, or development, and age-related diseases are not observed (76, 77) . No significant effect on voluntary food or water intake is observed in IGF-1R +/-mice, and metabolic rates are similar to controls, indicating unchanged efficiency of nutrient use. Furthermore, the knockout mutation has no effect on the onset or decline of repro- Fig. 2 . A summary of mice whose life span has been altered by genetic means. See the text for further discussion. tg, transgenic; KO, knockout; DC, dendritic cell; NER, nucleotide excision repair.
SAGE KE

SCIENCE OF AGING KNOWLEDGE ENVIRONMENT
ductive maturity, unlike the delays seen in GHR -/-mice (64). Many theories of aging posit that fitness in youth is achieved at the cost of life span as a result of, for example, increased metabolic activity. However, the lack of any overt phenotypes associated with life span extension in the IGF-1R and p66shc mutant mice appears to represent "cost-free longevity" (78) . (80) . Furthermore, the methylation status of the p66shc promoter has been found to affect the expression of forkhead proteins (72) .
FOXO transcription factors
A forkhead protein from a different subgroup, Foxm1b, restores proliferative capacity when overexpressed, alone or upon GH induction. However, GH treatment of Foxm1b -/-mice has no effect, indicating that Foxm1b is an essential downstream mediator of GH-induced proliferation (81) .
Life span studies on FOXO or Foxm1b knockout mice have not yet been published; however, allelic variations between individuals that affect longevity might exist. Analysis of human populations for two different polymorphic variants of the genes encoding IGF-1 pathway components IGF-1R, PI3K, IRS-1, and FOXO1A revealed an IGF-1R allelic variant that is associated with lowered plasma IGF-1 concentrations and is more prevalent in longer lived people. An allelic combination of IGF-1R and PI3K gene variants had a similar effect (82) . Longevity therefore appears to be influenced significantly by a complex set of overlapping gene functions within the GH/IGF-1 axis, both in humans and mice. This neurohormonal axis and some of the relevant intracellular signaling components are shown in Fig. 1 .
Insulin receptor mutations
Systemic hormonal and neuroendocrine control over longevity has been most extensively examined in the GH/IGF-1 pathway; however, other relevant signaling pathways do exist. Mutations affecting normal functioning of the insulin receptor result in shortened life span in humans and mice (83) (84) (85) (86) (87) . Therefore, the life span extension effects seen in hypoinsulinemic C. elegans mutants are likely caused by effects mediated by the counterparts of the GHR and IGF-1R signaling cascades.
On the other hand, Cre-loxP-mediated expression of a mutated insulin receptor (http://sageke.sciencemag.org/cgi/genedata/ sagekeGdbGene;308) in adipose tissue results in an 18% extension of mouse life span. No effect is seen on caloric intake, but reduced fat mass, lower incidence of age-related obesity, and correspondingly few obesity-related metabolic abnormalities are observed. This result suggests that at least some of the effects of CR might be separable from those of leanness. The metabolic rates of the mice were not altered significantly, indicating that there is an unknown longevity-inducing factor at work resulting directly from lowered fat content in the body and not from diet (88) .
Other mediators of murine longevity
Other factors might also play a role in the hormonal/neuroendocrine control of longevity. For example, mitochondrial membrane lipid saturation and therefore electromotive potential (which affects the rate of ROS accumulation) might be influenced by TSH via lipid desaturases (89) . Additionally, a young ovary transplanted into an old ovariectomized mouse greatly affects ensuing life expectancy, indicating that the ovary also contributes to hormonal life span regulation (90) .
The phenotypes of the mice discussed above are summarized in Fig. 2 . Various other models of life span extension not directly related to hormone or neuroendocrine activity exist and are mentioned in Fig. 2 , but a detailed discussion of these is beyond the scope of this Review. Other genetically altered mice in which longevity is affected include Klotho mice (http://sageke. sciencemag.org/cgi/content/full/sageke;2001/1/tg4): Inactivation of the klotho (http://sageke.sciencemag.org/cgi/genedata/ sagekeGdbGene;81) gene is associated with premature death in mice, and single-nucleotide polymorphisms in the human homolog KLOTHO (http://sageke.sciencemag.org/cgi/genedata/ sagekeGdbGene;222) have been identified and might be related to aging phenotypes and life span extension (91, 93) . Furthermore, antioxidants such as thioredoxin (94, 95) , peroxiredoxin (http://sageke.sciencemag.org/cgi/genedata/sagekeGdbGene;450) (96) , and Bcl-2, which suppresses ROS generation and prevents apoptosis (97, 98) , have been linked to life span or cellular survival in mice. Elements of the Ras signaling pathway also display effects on both antioxidative capacity and apoptosis, and elevated Ras expression is associated with cellular senescence in a number of model systems (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) .
Telomere length is another important factor that determines cellular life span (see "More Than a Sum of Our Cells" at http://sageke.sciencemag.org/cgi/content/full/2001/1/oa4). If cell senescence indeed contributes to organismal aging, then these effects must be localized to actively replicating cell types, such as cells of the immune system, as opposed to predominantly nonreplicative somatic cell types. Immunosenescence has been described as a characteristic of organismal aging that is altered by CR. Greater susceptibility to diseases in the elderly is likely a result of both a population shift from naïve to memory T cells (thus decreasing responses to novel antigens), and a lowered response in the remaining naïve T cells, which results in decreased T cell proliferation and cytokine reactivity (110-113) (and see "Immunity Challenge" at http://sageke. sciencemag.org/cgi/content/full/2003/23/oa1).
Consistent with this idea, the activity of telomerase (the enzyme that repairs telomere DNA sequences) is required for extended maintenance of T cell proliferative capacity (114) , and humans with shorter telomeres experience an eight-fold higher incidence of death caused by infectious diseases (115) (121, 122) . Heat shock response pathways (especially involving hsp70/mot2, a putative heat shock protein and negative regulator of p53) might also affect life span (123, 124) . However, the task of generating and analyzing appropriate mouse models has thus far limited investigation of these effects in mammals.
Modern developments in genomics and proteomics are increasingly facilitating large-scale screening in mammalian model systems. Transcriptional profiling via DNA microarrays or serial analysis of gene expression allows for monitoring of physiological changes and their underlying genetic correlates over time (see Bengtsson Viewpoint at http://sageke.sciencemag. org/cgi/content/full/sageke;2001/12/vp8). Gene expression profiling of CR, Snell, and Laron mice has revealed a wide range of chromosomal loci with activities differing from those of control mice (125) (126) (127) (128) . Quantitative trait locus (QTL) analysis allows for detection of genetic loci associated with a given trait and of variations between alleles at these loci (129) (and see Service Perspective at http://sageke.sciencemag.org/cgi/content/ full/2004/12/pe13 and Mackay Perspective at http://sageke. sciencemag.org/cgi/content/full/2004/17/pe17). QTL analysis of various inbred mouse strains has revealed several genetic regions associated with long-term survival and long life (130, 131) . A large-scale analysis of several genetically heterogeneous crossbred strains has also revealed that the strongest predictor of life span in mice is weight at 2 to 4 months of age (132) . This finding, in association with the identification of specific alleles associated with longevity, should provide us with physiological and genetic early life predictors of longevity, which will facilitate long-term large-scale studies of life span extension.
Conclusion
Genes associated with longevity have been extensively studied in lower organisms such as C. elegans, Saccharomyces cerevisiae, and Drosophila. Many of the logistic and technological limitations associated with equivalent research in mammalian models have been overcome, thus allowing for better insight into the human aging process. Large-scale analysis is being facilitated by newer approaches involving gene expression arrays and QTL analysis, as well as determination of early predictors of longevity.
CR is the only environmental factor that has been found to significantly and consistently extend life span in almost all examined species. Naturally long-lived mouse mutants have been found: Ames, Snell, and Little mice all display extended life span and significant reduction in aging-associated phenotypes, but at the cost of impaired metabolic function, including adverse effects on growth, development, and fertility. These effects resemble but do not completely overlap with the effects of CR.
The importance of hormonal and neuroendocrine influences on longevity is well established, especially with regard to the GH/IGF-1 axis. Mutations in this signaling pathway at or downstream of IGF-1R separate life span extension phenotypes from associated negative effects, resulting in "cost-free longevity" (78) . Analysis of mice in which components of the IGF-1 pathway such as IGF-1R and p66Shc have been genetically inactivated, together with work on other downstream effectors such as FOXO transcription factors, indicate that much of the observed extension of life span might be a result of increased antioxidative capacity. Inactivation of antioxidation enzymes such as thioredoxin and peroxiredoxin also affects life span. However, cultured human cells appear to be inherently more stress-resistant than mouse cells (see Hornsby Perspective at http://sageke. sciencemag.org/cgi/content/full/2003/30/pe21), which may call for caution in applying research carried out in mice to human biology. Other signaling molecules and pathways have also been implicated in the control of aging, including the insulin receptor, ovarian neuroendocrine control, Ras, the heat shock response, and factors affecting immunosenescence.
Research into aging in mammalian systems (beyond the investigation of aging-related diseases) is still in its infancy. Life span analyses must be performed on many more mouse strains in which components of the GH/IGF-1 signaling system have been inactivated. Similar studies will need to be carried out on other hormonal, neuroendocrine, and genetic pathways, particularly involving global regulators of gene expression such as histone deacetylases that may contribute to setting an "aging" pattern of gene expression. Results from these and other models of aging will contribute greatly to our understanding of organismal aging and will be fundamental to the development of future strategies of intervention in the ubiquitous group of processes we call aging.
